Cover Image

Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis

Triple-negative breast cancer (TNBC) is a subtype of aggressive breast cancer and characterized by a lack of the expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2. BRCA genes are tumor-suppressor genes that are involved in DNA damage repair and mutat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haixia Chen (Author), Jianming Wu (Author), Zhihong Zhang (Author), Yong Tang (Author), Xiaoxuan Li (Author), Shuangqing Liu (Author), Shousong Cao (Author), Xianzhu Li (Author)
Format:	Book
Published:	Frontiers Media S.A., 2018-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunotherapy for Triple-Negative Breast Cancer
by: Yifeng Cao, et al.
Published: (2021)

Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation?
by: Sabah Alaklabi, et al.
Published: (2023)

Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis
by: Xueqiong Xun, et al.
Published: (2023)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
by: Guoyu Wu, et al.
Published: (2022)

Role of flavonoids in inhibiting triple-negative breast cancer
by: Shuai Wang, et al.
Published: (2024)

The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer-A Meta-Analysis
by: Zilin Zhang, et al.
Published: (2021)

Oncolytic viruses for triple negative breast cancer and beyond
by: Shengye Jin, et al.
Published: (2021)

Vulnerability of Triple-Negative Breast Cancer to Saponin Formosanin C-Induced Ferroptosis
by: Hsin-Chih Chen, et al.
Published: (2022)

Target Analysis and Mechanism of Podophyllotoxin in the Treatment of Triple-Negative Breast Cancer
by: Wenfeng Zhang, et al.
Published: (2020)

Brain Metastasis in Triple-Negative Breast Cancer
by: Eduarda Bustamante, et al.
Published: (2024)

Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021)

Neighborhood Social Determinants of Triple Negative Breast Cancer
by: Fokhrul Hossain, et al.
Published: (2019)

All-stage targeted therapy for the brain metastasis from triple-negative breast cancer
by: Zimiao Luo, et al.
Published: (2023)

SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
by: Peng Liu, et al.
Published: (2018)

Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
by: Avantika Lal, et al.
Published: (2019)

Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Pairwise and Network Meta-Analysis of Pathological Complete Response
by: Zeng-Jie Weng MM, et al.
Published: (2021)

Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer
by: Yuqin Lin, et al.
Published: (2023)

Induced Cell Cycle Arrest in Triple-Negative Breast Cancer by Combined Treatment of Itraconazole and Rapamycin
by: Hua-Tao Wu, et al.
Published: (2022)

BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
by: Yinmei Zhang, et al.
Published: (2024)

Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Xiaoxuan Li, et al.
Published: (2018)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014)

HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
by: Cristina Maccallini, et al.
Published: (2022)

The Roles of DNA Demethylases in Triple-Negative Breast Cancer
by: Shoghag Panjarian, et al.
Published: (2021)

Triple-Negative Lobular Breast Cancer Causing Hydronephrosis
by: Michael Chahin DO, et al.
Published: (2020)

Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021)

Efficacy and Safety of PD-1/PD-L1 Inhibitors in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
by: Zhen-Yu Li, et al.
Published: (2023)

Recent Progress of Multifunctional Molecular Probes for Triple-Negative Breast Cancer Theranostics
by: Deyi Zhao, et al.
Published: (2024)

Current landscape of personalized clinical treatments for triple-negative breast cancer
by: Jun Zhang, et al.
Published: (2022)

Prognostic impact of PTK6 expression in triple negative breast cancer
by: Yuexia Chen, et al.
Published: (2023)

Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast Cancer
by: Qiu Y, et al.
Published: (2024)

Immunoadjuvant Nanoparticles as Trojan Horses for Enhanced Photo-Immunotherapy in the Treatment of Triple-Negative Breast Cancer
by: Jinxian Wu, et al.
Published: (2022)

The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer after neoadjuvant treatment: a single institution experience
by: D. A. Enaldieva, et al.
Published: (2023)

A case report and literature review on a rare subtype of triple-negative breast cancer in children
by: Lexiang Shi, et al.
Published: (2023)

Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
by: Wenjie Zhao, et al.
Published: (2021)

Update on triple-negative breast cancer: prognosis and management strategies
by: Brouckaert O, et al.
Published: (2012)

Editorial: Targeting triple negative breast cancer by natural compounds
by: Shashank Kumar, et al.
Published: (2023)